Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study

Therese Torgersen Bigseth; Mats Fredriksen; Jens Egeland; Eivind Andersen; Ole Andreas Andreassen; Gry Bang-Kittilsen; Ragnhild Sorum Falk; Tom Langerud Holmen; Egil Wilhelm Martinsen; Jon Mordal; Jimmi Nielsen; Nils Eiel Steen; Thor Ueland; Torkel Vang; John Abel Engh

doi:10.1016/j.schres.2020.11.051

Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study

Therese Torgersen Bigseth^*
, Mats Fredriksen
, Jens Egeland
, Eivind Andersen
, Ole Andreas Andreassen
, Gry Bang-Kittilsen
, Ragnhild Sorum Falk
, Tom Langerud Holmen
, Egil Wilhelm Martinsen
, Jon Mordal
, Jimmi Nielsen
, Nils Eiel Steen
, Thor Ueland
, Torkel Vang
, John Abel Engh

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Schizophrenia Research
Vol/bind	228
Sider (fra-til)	190-192
Antal sider	3
ISSN	0920-9964
DOI	https://doi.org/10.1016/j.schres.2020.11.051
Status	Udgivet - feb. 2021

Bibliografisk note

Funding Information:
Funding/support: The work was supported by Vestfold Hospital Trust, Division of Mental Illness and Drug Addiction, the Research Council of Norway (#223273, #283798), South East Health Authority (#2016025, #2019108,), the Josef and Haldis Andresen's foundation (#15/145518/HTR), Torgeir Lindvig's Trust (#2013). We would also like to thank the staff at EPHAPS and NORMENT for their part in recruiting participants and collecting data, all the participants for their time and effort, as well as Erikka Grose-Demuth for editing the manuscript.

Finansiering

Funding/support: The work was supported by Vestfold Hospital Trust, Division of Mental Illness and Drug Addiction, the Research Council of Norway (#223273, #283798), South East Health Authority (#2016025, #2019108,), the Josef and Haldis Andresen's foundation (#15/145518/HTR), Torgeir Lindvig's Trust (#2013). We would also like to thank the staff at EPHAPS and NORMENT for their part in recruiting participants and collecting data, all the participants for their time and effort, as well as Erikka Grose-Demuth for editing the manuscript.

Adgang til dokumentet

10.1016/j.schres.2020.11.051

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

Bigseth, T. T., Fredriksen, M., Egeland, J., Andersen, E., Andreassen, O. A., Bang-Kittilsen, G., Falk, R. S., Holmen, T. L., Martinsen, E. W., Mordal, J., Nielsen, J., Steen, N. E., Ueland, T., Vang, T., & Engh, J. A. (2021). Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study. Schizophrenia Research, 228, 190-192. https://doi.org/10.1016/j.schres.2020.11.051

Bigseth, TT, Fredriksen, M, Egeland, J, Andersen, E, Andreassen, OA, Bang-Kittilsen, G, Falk, RS, Holmen, TL, Martinsen, EW, Mordal, J, Nielsen, J, Steen, NE, Ueland, T, Vang, T & Engh, JA 2021, 'Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study', Schizophrenia Research, bind 228, s. 190-192. https://doi.org/10.1016/j.schres.2020.11.051

@article{74f199e6928d42458c8962f94a3dd52c,

title = "Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study",

author = "Bigseth, \{Therese Torgersen\} and Mats Fredriksen and Jens Egeland and Eivind Andersen and Andreassen, \{Ole Andreas\} and Gry Bang-Kittilsen and Falk, \{Ragnhild Sorum\} and Holmen, \{Tom Langerud\} and Martinsen, \{Egil Wilhelm\} and Jon Mordal and Jimmi Nielsen and Steen, \{Nils Eiel\} and Thor Ueland and Torkel Vang and Engh, \{John Abel\}",

note = "Funding Information: Funding/support: The work was supported by Vestfold Hospital Trust, Division of Mental Illness and Drug Addiction, the Research Council of Norway (\#223273, \#283798), South East Health Authority (\#2016025, \#2019108,), the Josef and Haldis Andresen's foundation (\#15/145518/HTR), Torgeir Lindvig's Trust (\#2013). We would also like to thank the staff at EPHAPS and NORMENT for their part in recruiting participants and collecting data, all the participants for their time and effort, as well as Erikka Grose-Demuth for editing the manuscript. ",

year = "2021",

month = feb,

doi = "10.1016/j.schres.2020.11.051",

language = "English",

volume = "228",

pages = "190--192",

journal = "Schizophrenia Research",

issn = "0920-9964",

publisher = "Elsevier",

}

TY - JOUR

T1 - Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia

T2 - A case-control study

AU - Bigseth, Therese Torgersen

AU - Fredriksen, Mats

AU - Egeland, Jens

AU - Andersen, Eivind

AU - Andreassen, Ole Andreas

AU - Bang-Kittilsen, Gry

AU - Falk, Ragnhild Sorum

AU - Holmen, Tom Langerud

AU - Martinsen, Egil Wilhelm

AU - Mordal, Jon

AU - Nielsen, Jimmi

AU - Steen, Nils Eiel

AU - Ueland, Thor

AU - Vang, Torkel

AU - Engh, John Abel

N1 - Funding Information: Funding/support: The work was supported by Vestfold Hospital Trust, Division of Mental Illness and Drug Addiction, the Research Council of Norway (#223273, #283798), South East Health Authority (#2016025, #2019108,), the Josef and Haldis Andresen's foundation (#15/145518/HTR), Torgeir Lindvig's Trust (#2013). We would also like to thank the staff at EPHAPS and NORMENT for their part in recruiting participants and collecting data, all the participants for their time and effort, as well as Erikka Grose-Demuth for editing the manuscript.

PY - 2021/2

Y1 - 2021/2

U2 - 10.1016/j.schres.2020.11.051

DO - 10.1016/j.schres.2020.11.051

M3 - Comment/debate

C2 - 33450603

AN - SCOPUS:85099228044

SN - 0920-9964

VL - 228

SP - 190

EP - 192

JO - Schizophrenia Research

JF - Schizophrenia Research

ER -